{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:35:47Z","timestamp":1794652547640,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The usage of guideline-directed medical therapy (GDMT) in the treatment of heart failure (HF) has shown to reduce morbidity and mortality. However, majority of the HF patients do not receive GDMT or do not achieve the target dose. Literature has shown that the patients who are managed in HF clinics receive GDMT and target doses of disease-modifying drugs (DMD) when compared to those treated in other general cardiology outpatient departments (OPD\u2019s). It was a retrospective hospital-based study in which patients treated in HF clinic and other cardiology OPD in the year of 2017 were included (200 patients in each arm). The aim of this study was to assess the impact of heart failure clinics in medication therapy management including usage of guideline-directed medical therapy, if target dose specified by the guideline is achieved and time to reach target dose in comparison to other general cardiology OPD\u2019s. IRB and IEC approval were obtained before the commencement of the study. Data relevant to the study were obtained from the electronic medical record (EMR) and were compared between the study groups to see for the adherence to guideline and achievement of target doses. Data storage and analysis were performed using SPSS Version 24. A significance level of 5% was used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The usage of GDMT was higher in HF clinic when compared to other cardiology OPD (81% vs 55%,<jats:italic>P<\/jats:italic>= 0.001). A significantly higher number of patients in HF clinic achieved target dose when compared to other cardiology OPD (58% vs 29% -betablockers, 45% vs 9% -ACEI\/ARB\/ARNI,<jats:italic>P<\/jats:italic>= 0.000). Moreover, the number of eligible patients receiving DMD was found to be higher in HF clinic (98% vs 85% -betablockers, 69% vs 44% -ACEI\/ARB\/ARNI, 76% vs 44% -MRA). Also, the patients in HF clinic attained the target doses faster when compared to other cardiology OPD. In addition, there was better improvement in ejection fraction, as well as decreased rate of rehospitalisation and mortality in patients managed in HF clinic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HF clinics were compared with other cardiology OPD for various parameters and it was observed that HF clinics were better than other cardiology OPD in maintaining the medication therapy management.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s43044-020-00088-8","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T12:03:37Z","timestamp":1598270617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department"],"prefix":"10.1186","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-5214","authenticated-orcid":false,"given":"Jeeva","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephy","family":"P S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suja","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"88_CR1","doi-asserted-by":"crossref","unstructured":"Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M. H, et al. ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 2013;62(16) 2013 Oct 15. (e147-239)","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"88_CR2","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM et al (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 136:e137\u2013e161","journal-title":"Circulation."},{"issue":"27","key":"88_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowsk","year":"2016","unstructured":"Ponikowsk P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) 2016 ECS guidelines for heart failure treatment. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"key":"88_CR4","first-page":"1","volume":"22","author":"K Balakumaran","year":"2018","unstructured":"Balakumaran K, Patil A, Marsh S, Ingrassia J, Kuo CL et al (2018) Evaluation of guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction. Int J Cardiol Heart Vasc 22:1\u20135","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"9145","key":"88_CR5","first-page":"9","volume":"353","author":"CIBIS-II Writers","year":"1999","unstructured":"CIBIS-II Writers (1999) The cardiac insufficiency Bisoprolol study II (CIBIS-II): a randomized trial. Lancet 353(9145):9\u201313","journal-title":"Lancet"},{"issue":"23","key":"88_CR6","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn JN, Togoni G, On behalf of Valsartan Heart Failure Trial Investigators (2001) A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure. N Engl J Med 345(23):1667\u20131675","journal-title":"N Engl J Med"},{"key":"88_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERITHF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"88_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"issue":"17","key":"88_CR9","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H (2002) Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 106(17):2194\u20132199","journal-title":"Circulation."},{"issue":"9386","key":"88_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","volume":"362","author":"CB Granger","year":"2003","unstructured":"Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet. 362(9386):772\u2013776","journal-title":"Lancet."},{"issue":"10","key":"88_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709\u2013717","journal-title":"N Engl J Med"},{"issue":"1","key":"88_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11\u201321","journal-title":"N Engl J Med"},{"issue":"5","key":"88_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ejhf.510","volume":"18","author":"M Komajda","year":"2016","unstructured":"Komajda M, Anker SD, Cowie MR, Filippatos GS, Mengelle B, Ponikowski P, Tavazzi L (2016) Physicians\u2019 adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from QUALIFY global survey. Eur J Heart Fail 18(5):514\u2013522","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"88_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5694\/j.1326-5377.2004.tb06178.x","volume":"181","author":"SM Phillips","year":"2004","unstructured":"Phillips SM, Marton RL, Tofler GH (2004) Barriers to diagnosing and managing heart failure in primary care. Med J Aust 181(2):78\u201381","journal-title":"Med J Aust"},{"issue":"20","key":"88_CR15","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.jacc.2017.03.563","volume":"69","author":"AS Bhatt","year":"2017","unstructured":"Bhatt AS, Devore AD, Dewald TA, Swedberg K, Mentz RJ (2017) Achieving a maximally tolerated beta-blocker dose in heart failure patients: is there room for improvement? J Am Coll Cardiol 69(20):2542\u20132550","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"88_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jacc.2015.12.045","volume":"67","author":"GC Fonarow","year":"2016","unstructured":"Fonarow GC, Ziaeian B (2016) Gaps in adherence to guideline-directed medical therapy before defibrillator implantation. J Am Coll Cardiol 67(9):1070\u20131073","journal-title":"J Am Coll Cardiol"},{"key":"88_CR17","doi-asserted-by":"crossref","unstructured":"Driscoll A., Srivastava P., Toia D., Gibcus J., Hare D.L. A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy\u2014a randomized controlled trial. BMC Res Notes. 2014;7 (668-0500)","DOI":"10.1186\/1756-0500-7-668"},{"issue":"7","key":"88_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamacardio.2016.2332","volume":"1","author":"A Driscoll","year":"2016","unstructured":"Driscoll A, Currey J, Tonkin AM (2016) Nurse-led titration of angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers in patients with heart failure with reduced ejection fraction. JAMA Cardiol 1(7):842\u2013843","journal-title":"JAMA Cardiol"},{"key":"88_CR19","doi-asserted-by":"crossref","unstructured":"Driscoll A., Currey J., Tonkin A., Krum H. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. Cochrane Database Syst. Rev. 2015;12 (CD009889. doi(12):CD009889)","DOI":"10.1002\/14651858.CD009889.pub2"},{"key":"88_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejheart.2004.09.009","volume":"7","author":"A Jain","year":"2005","unstructured":"Jain A, Mills P, Nunn LM, Butler J, Luddington L, Ross V (2005) Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail 7:405\u2013410","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"88_CR21","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/01.CIR.0000070952.08969.5B","volume":"107","author":"M Ansari","year":"2003","unstructured":"Ansari M, Shlipak MG, Heidenreich PA (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 107(22):2799\u20132804","journal-title":"Circulation."},{"issue":"3","key":"88_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jama.292.3.344","volume":"292","author":"VL Roger","year":"2004","unstructured":"Roger VL, Weston SA, Redfield MM, Hellerman-Homan JP, Yawn BP, Jacobsen SJ (2004) Trends in heart failure incidence and survival in a community-based population. J Am Med Assoc 292(3):344\u2013350","journal-title":"J Am Med Assoc"},{"key":"88_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archinte.164.7.769","volume":"164","author":"P Tandon","year":"2004","unstructured":"Tandon P, McAlister FA, Tsuyuki RT, Hervas-Malo M, Dupuit R, Ezekowitz J et al (2004) THE use of brta-blockers in a tertiary care heart failure clinic. Arch Internal Med 164:769\u2013774","journal-title":"Arch Internal Med"},{"issue":"666","key":"88_CR24","first-page":"1","volume":"7","author":"A Driscoll","year":"2014","unstructured":"Driscoll A, Srivastava P, Toia D, Givcus G, Hara D (2014) A nurse led up titration clinic improves chronic heart failure optimisation of beta-adrenergic receptor blocking therapy-a randomised controlled trial. BMC Res Notes 7(666):1\u20139","journal-title":"BMC Res Notes"},{"issue":"4","key":"88_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/phar.2091","volume":"34","author":"RH Tran","year":"2018","unstructured":"Tran RH, Aldemerdash A, Chang P, Sueta C, Kaufman B, Asafu-adjei J et al (2018) Guideline directed medical therapy and survival following hospitalisation in patients with heart failure. Pharmacotherapy. 34(4):406\u2013416","journal-title":"Pharmacotherapy."},{"issue":"3","key":"88_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/clc.22519","volume":"39","author":"Y Pokharel","year":"2016","unstructured":"Pokharel Y, Wei J, Hira R, Kalra A, Shore S, Kerkar P, Kumar G et al (2016) Guideline directed medication use in patients with heart failure with reduced ejection fraction in India: American college of cardiology\u2019s PINNACLE India quality improvement program. Clin Cardiol 39(3):145\u2013149","journal-title":"Clin Cardiol"},{"key":"88_CR27","unstructured":"Greene S, Fonarow G, Devore A, Sharma P, Baduganathan M, Albert N et al (2019) Longitudinal titration of medical therapy for heart failure with reduced ejection fraction: CHAMP-HF registry. J Am Coll Cardiol:211\u2013215"},{"issue":"8","key":"88_CR28","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.cardfail.2018.07.380","volume":"24","author":"C Cornelio","year":"2018","unstructured":"Cornelio C, DiPalo KE (2018) Guideline directed medical therapy in hospitalized heart failure patients: still under prescribed despite updated guidelines and over 20\u2009years of experience. J Cardiac Fail 24(8):S100","journal-title":"J Cardiac Fail"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-020-00088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-020-00088-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-020-00088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T17:10:50Z","timestamp":1668013850000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-020-00088-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1186\/s43044-020-00088-8","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IRB and IEC approval were obtained before the commencement of the study. This study was approved by the ethics committee of Lisie Hospital, Kochi, with approval number Reg no: ECR\/40\/inst\/KL\/2013\/RR-16. Informed consent was obtained from the subjects. Written informed consent was obtained from all the study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"53"}}